Haafor (Singapore)’s AbbVie ABBV Stock Holding History

Haafor (Singapore)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$229K	–	160
2020 Q1	$229K	Buy	3,000 +335	+13%	+$28.5K	0.37%	118
2019 Q4	$236K	Buy	+2,665	New	+$221K	0.16%	212

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Haafor (Singapore)'s ABBV Position: Q2 2020 in Review

Haafor (Singapore) sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 3,000 shares — an estimated $229K sold.

Haafor (Singapore) first reported a position in ABBV in Q4 2019 and held it in 2 quarters. The position peaked at $236K in Q4 2019. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Haafor (Singapore) reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
Haafor (Singapore) sold 3,000 AbbVie shares in Q2 2020, an estimated $229K.
Haafor (Singapore) first reported a position in AbbVie in Q4 2019 and held it in 2 quarters.
Haafor (Singapore)'s AbbVie position peaked at $236K in Q4 2019.
2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Haafor (Singapore)'s 13F filing for Q2 2020, filed 13 Aug 2020.